GARDP, Shionogi and CHAI announce license and collaboration agreements to expand global access to novel antibiotic cefiderocol

Read the announcement

Accelerating the development of treatments for drug-resistant infections, for every person who needs them

The Global Antibiotic Research and Development Partnership mobilizes resources and partners to develop lifesaving treatments for drug-resistant infections.

0 million

people die of drug-resistant infections every year

0 million

people could be pushed into extreme poverty by drug resistance by 2050

0 billion

dollars in annual financial losses due to hospital infections in the US and Europe alone

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.